anika research(anik) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : anika research(anik)

ANIK 9.780

+0.4%

3:05 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Eduardo Canto who wrote (88)	1/18/1998 4:55:00 PM
From: John McCarthy	Read Replies (1) of 328

Eduardo - <<Notice that BIOX filed a law suit that had absolutely no merrit against Anik right on the day that Anik was going to set the offering price for its secondary (http://biz.yahoo.com/bw/971125/anika_therapeutics_1.html). Quite a dirty trick,>> If this was their motive, I agree, it sucks. And was absolutely unethical. BTW - you do realize BMY has kept a drug called PAXENE off the market until the year 2004. Paxene is the equivalent of Taxol. Taxol is primarily used for Breast and Ovarian cancers. With their action, they have a 'lock' on this puppy. And they did this in the shitest of ways, Taxol, whose annul sales are around $800 million, was filed as an ORPHAN DRUG with respect to the K.S. indication. Yes - its legal - but not ethical or the intent of the ODS law. And lastly, nobody gives a shit. Regards, John

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next